Regionalization of care for acute type a aortic dissection: utilizing mixed methods toward bottom-up health system interventions in emergent surgical care - acute type a aortic dissection (ataad) is a…

Active Project Grant Awarded Last action

Award ID
F32HL179865
Recipient
Awarding agency
Obligated
$391,700

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 46% complete
Originally
Place of performance
Boston, MA 02114, USA

Award details come from USAspending.gov.

About this award

The National Heart, Lung, and Blood Institute awarded The General Hospital Corporation (doing business as Massachusetts General Hospital) $391,700 under the Cardiovascular Diseases Research program (CFDA 93.837) on February 15, 2026.

The award funds mixed-methods health services research to optimize the regionalization of care for acute type A aortic dissection (ATAAD) and increase appropriate interfacility transfer of ATAAD patients from low-volume to high-volume aortic centers. The research will conduct quantitative analysis of state-level administrative claims databases and emergency medical transport services electronic medical records to define current regionalization patterns, measure transport time and case volume thresholds that optimize survival benefit, and inform targeted interventions to align transfer patterns with American College of Cardiology and American Heart Association guidelines.

Work is performed in Boston, Massachusetts, with a period of performance from February 15, 2026 through August 17, 2027. The assistance type is a Project Grant, an investigator-initiated research award supporting the research agenda of the principal investigator rather than a government-directed procurement.

Description

Regionalization of care for acute type a aortic dissection: utilizing mixed methods toward bottom-up health system interventions in emergent surgical care - acute type a aortic dissection (ataad) is a life-threatening event that carries a mortality rate of 15-30% even with emergent surgical intervention. Patients with ataad face operative mortality rates that exhibit a striking difference according to providing center experience, with those treated at high-volume aortic centers afforded a 10% or greater survival benefit compared to those treated at low-volume centers. And yet, 48% of ataad patients undergo surgery at low-volume centers. This is despite a robust U.S. Study demonstrating that the delay inherent to interfacility transfer to high-volume centers does not offset a 7.2% absolute risk reduction in operative mortality. What's more, one third of patients who incur the potential risk associated with interfacility transfer are transferred to low-volume centers. Consequently, contemporary guidelines published by the american college of cardiology and the american heart association (2022) recommend the transfer of stable ataad patients from low- to high-volume centers. However, current transfer patterns deviate from these recommendations. The proposed research will utilize mixed methods health services research to improve the care of patients with ataad by defining parameters that optimize the regionalization of care and informing targeted interventions to increase the frequency of appropriate interfacility transfer to high-volume aortic centers. Quantitative analysis of state-level administrative claims databases and emergency medical transport services electronic medical records will be used to define the population distribution in the current level of regionalization of care for ataad and measure the transport time and case volume thresholds that optimize the survival benefit of interfacility transfer of ataad patients from no- or low-volume to high-volume aortic centers. Qualitative analysis will be employed to identify facilitators of and barriers to the regionalization of care for ataad through semi-structured interview of emergency medicine and cardiac surgery providers. This work will establish optimal parameters for the safe regionalization of care for ataad, characterize geographically granular facilitators of appropriate interfacility transfer, and ultimately improve survival rates for ataad patients. The knowledge that emerges from this work will inform an implementation science proposal to design and test a targeted intervention to regionalize emergent, specialized surgical care, improving patient outcomes, reducing complications, and lowering healthcare costs. By performing this work, DR. Sabatino will receive mentored training in mixed methodology inclusive of quantitative statistical analysis, interview conduct and qualitative analysis, geospatial analysis, and the clinical science of cardiac and thoracic aortic surgery, facilitating her development into an independent surgeon-scientist and a leader in cardiac surgery.

Transactions

Action Obligated Date
Amendment $100,580
Amendment $97,040
Amendment $0
Amendment $97,040
Amendment $97,040
Original award $0

Quick answers

Who received award F32HL179865?

F32HL179865 was awarded to The General Hospital Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on February 15, 2026.

How much is award F32HL179865 worth?

$391,700 has been obligated on F32HL179865.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award